CEUnits – continuing education at home
CEUnits – continuing education at home
Facebook-f Linkedin-in
0
Your Cart
No products in the cart.

MFT / LCSW

Treatment of Depression in Children and Adolescents: A Systematic Review

1.00 - CE credit hours training

$6.00 - Cost of course

This page contains important information about the course, including training details, a comprehensive course description, learning objectives, and source references. We encourage you to review each section to gain a clear understanding of the course content, educational goals, and supporting materials before beginning your training and taking the POST TEST below.

Target audience and instructional level of this course: foundational
There is no known conflict of interest or commercial support related to this CE program.

Treatment of Depression in Children and Adolescents: A Systematic Review

Follow the link below, read the material and then take the 6 question post test

Read the Course Material:
Treatment of Depression in Children and Adolescents: A Systematic Review

**Note: Course content can be found on
pages ES-1 to ES-22 of the document.

6 Questions

1. Which of the following disorders was not examined in the course article?
2. The course article examined the efficacy and comparative effectiveness of which of the following:
3. The acronym SOE stands for Strength of Effectiveness:
4. The studies in the course article provided enough evidence of associations between suicidality and SSRIs as a drug class:
5. Which of the following are differences between the Food and Drug Administration's systematic review of 24 trials of participants with depression in 2014 and this analysis:
6. Results from the course article suggest that:
Depressive disorders can affect long-term mental and physical health functioning among children and adolescents, including increased risk of suicide. Despite access to several nonpharmacological, pharmacological, and combined treatment options for childhood depression, clinicians contend with sparse evidence and are concerned about harms associated with treatment.
This course summarizes the results of a systematic review to evaluate the efficacy, comparative effectiveness, and moderators of benefits and harms of available nonpharmacological and pharmacological treatments for children and adolescents with a confirmed diagnosis of a depressive disorder (DD)--major depressive disorder (MDD), persistent depressive disorder (previously termed dysthymia) or DD not otherwise specified.
  1. describe the empirical evidence reviewed in the course article.
  2. outline the findings in the course article in relationship to what is already know about the benefits of various nonpharmacological, pharmacological and combination treatments for children and adolescents with Depressive Disorders.
  3. compile a list of future research needs related to the treatment of depression in children and adolescents.
Prepared by the following investigators at RTI International?University of North Carolina at Chapel Hill Evidence-based Practice Center, Research Triangle Park, NC:

Meera Viswanathan, Ph.D.
Sara M. Kennedy, M.P.H.
Joni McKeeman, Ph.D.
Robert Christian, M.D.
Manny Coker-Schwimmer, M.P.H.
Jennifer Cook Middleton, Ph.D.
Carla Bann, Ph.D.
Linda Lux, M.P.A.
Charli Randolph, B.A.
Valerie Forman-Hoffman, Ph.D., M.P.H.